Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-κB activation

Nitric Oxide - Biology and Chemistry

Volumn 19, Issue 2, 2008, Pages 138-145

  Hammadi, Amar ^a   Billard, Christian ^a   Faussat, Anne Marie ^a   Kolb, Jean Pierre ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Apoptosis; B CLL; NF B; NO; TLR

Indexed keywords

3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; AUTOANTIGEN; B LYMPHOCYTE RECEPTOR; CASPASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PARAPROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; WEDELOLACTONE;

ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

AGED; AGED, 80 AND OVER; APOPTOSIS; FEMALE; GENE EXPRESSION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 47049101962     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2008.04.017     Document Type: Article

References (36)

1. Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., and Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19 (1998) 711-721
2. Xu W., Liu L.Z., Loizidou M., Ahmed M., and Charles I.G. The role of nitric oxide in cancer. Cell Res. 12 (2002) 311-320
3. Lancaster Jr. J.R., and Xie K. Tumors face NO problems?. Cancer Res. 66 (2006) 6459-6462
4. Roberts D.D., Isenberg J.S., Ridnour L.A., and Wink D.A. Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis. Clin. Cancer Res. 13 (2007) 795-798
5. Zhao H., Dugas N., Mathiot C., Dugas B., Sigaux F., and Kolb J.P. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood 92 (1998) 1031-1043
6. Kolb J.P., Roman V., Mentz F., Zhao H., Rouillard D., Dugas N., Dugas B., and Sigaux F. Contribution of nitric oxide to the apoptotic process in human B cell chronic lymphocytic leukemia. Leuk. Lymphoma 40 (2001) 243-257
7. Levesque M.C., Misukonis M.A., O'Loughlin C.W., Chen Y., Beasley B.E., Wilson D.L., Adams D.J., Silber R., and Weinberg J.B. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells. Leukemia 17 (2003) 442-450
8. Levesque M.C., Ghosh D.K., Beasley B.E., Chen Y., Volkheimer A.D., O'Loughlin C.W., Gockerman J.P., Moore J.O., and Weinberg J.B. CLL cell apoptosis induced by nitric oxide synthase inhibitors: correlation with lipid solubility and NOS1 dissociation constant. Leuk. Res. 32 (2008) 1061-1070
9. Roman V., Billard C., Kern C., Ferry-Dumazet H., Izard J.C., Mohammad R., Mossalayi D.M., and Kolb J.P. Analysis of resveratrol-induced apoptosis in human B-cell chronic leukemia. Br. J. Haematol. 117 (2002) 1-10
10. Quiney C., Dauzonne D., Kern C., Fourneron J.D., Izard J.C., Mohammad R.M., Kolb J.P., and Billard C. Flavones and polyphenols inhibit the NO pathway during apoptosis of leukemia B-cells. Leuk. Res. 28 (2004) 851-861
11. kip1 in malignant cells from B-cell chronic lymphocytic leukemia. Leukemia 17 (2003) 2345-2443
12. Quiney C., Billard C., Faussat A.M., Salanoubat C., Ensaf A., Naït-Si Y., Fourneron J.D., and Kolb J.P. Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia. Leukemia 20 (2006) 491-497
13. Billard C., Menasria F., Quiney C., Faussat A.M., and Kolb J.P. Flavopiridol-induced iNOS downregulation during apoptosis of chronic lymphocytic leukemia cells is caspase-dependent. Leuk. Res. 32 (2008) 755-760
14. Cioca D.P., and Kitano K. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia. Leukemia 16 (2002) 335-343
15. Secchiero P., di Iasio M.G., Gonelli A., Barbarotto E., Melloni E., Tiribelli M., Chiaruttini C., and Zauli G. Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70. J. Cell. Physiol. 213 (2007) 229-236
16. Chiorazzi N., Hatzi K., and Albesiano E. B-Cell chronic lymphocytic leukemia, a clonal disease of B Lymphocytes with receptors that vary in specificity for (auto) antigens. Ann. NY Acad. Sci. 1062 (2005) 1-12
17. Kay N.E., Hamblin T.J., Jelinek D.F., Dewald G.W., Byrd J.C., Farag S., Lucas M., and Lin T. Chronic lymphocytic leukemia. Hematology (Am. Soc. Hematol. Educ. Program) (2002) 193-213
18. Messmer B.T., Albesiano E., Efremov D.G., Ghiotto F., Allen S.L., Kolitz J., Foa R., Damle R.N., Fais F., Messmer D., Rai K.R., Ferrarini M., and Chiorazzi N. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J. Exp. Med. 200 (2004) 519-525
19. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004) 499-511
20. Barton G.M., and Medzhitov R. Toll-like receptor signaling pathways. Science 300 (2003) 1524-1525
21. de Vera M.E., Shapiro R.A., Nussler A.K., Mudgett J.S., Simmons R.L., Morris Jr. S.M., Billiar T.R., and Geller D.A. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc. Natl. Acad. Sci. USA 93 (1996) 1054-1059
22. Kobori M., Yang Z., Gong D., Heissmeyer V., Zhu H., Jung Y.K., Gakidis M.A., Rao A., Sekine T., Ikegami F., Yuan C., and Yuan J. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ. 11 (2004) 123-130
23. Pierce J.W., Schoenleber R., Jesmok G., Best J., Moore S.A., Collins T., and Gerritsen M.E. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272 (1997) 21096-21103
24. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., and Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2 (2002) 196-200
25. Jurk M., Heil F., Vollmer J., Schetter C., Krieg A.M., Wagner H., Lipford G., and Bauer S. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 3 (2002) 499-501
26. Dimmeler S., Haendeler J., Nehls M., and Zeiher A.M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta converting enzymes (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185 (1997) 601-607
27. Grandjenette C., Kennel A., Faure G.C., Bene M.C., and Feugier P. Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells. Haematologica 92 (2007) 1279-1281
28. Spaner D.E., and Masellis A. Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia. Leukemia 21 (2007) 53-60
29. Peng S.L. Signaling in B cells via Toll-like receptors. Curr. Opin. Immunol. 17 (2005) 230-236
30. Banerjee A., and Gerondakis S. Coordinating TLR-activated signaling pathways in cells of the immune system. Immunol. Cell Biol. 85 (2007) 420-424
31. Nunokawa Y., Oikawa S., and Tanaka S. Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-kappaB dependent mechanism. Biochem. Biophys. Res. Commun. 223 (1996) 347-352
32. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., and Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
33. Diebold S.S., Kaisho T., Hemmi H., Akira S., and Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004) 1529-1531
34. Caligaris-Cappio F. The microenvironment in CLL. Br. J. Haematol. 123 (2003) 380-388
35. Goodman M.G., Wormsley S.B., Spinosa J.C., and Piro LD L.D. Loxoribine induces CLL cells to traverse the cell cycle. Blood 84 (1994) 3457-3464
36. Spaner D.E., Shi Y., Mena J., Hammond C., Tomic J., He L., Tomai M.A., Miller R.L., Booth J., and Radvanyi L. Immunomodulatory effects of TLR7 activation on CLL cells. Leukemia 20 (2006) 286-295